Production has started
TELTOHEART
TeltoHeart – a multifunctional smart wristband has a remarkable array of features, catering to users seeking a comprehensive solution for fitness, wellness, and even medical monitoring when using with the MyHealth app², offering capabilities like 6-lead5 ECG recording and detection of atrial fibrillation and other arrhythmias.
The information contained in this website is for general information purposes only. The Disclaimer is available here.
SMART WRISTBAND WITH
6-LEAD ECG RECORDING²
High precision electrocardiogram recording for your physician to analyse.
ATRIAL FIBRILLATION DETECTION
Patented high specificity algorithm for real time heart arrythmia detection³.
CONTINUOUS HEART RATE MONITORING
A photoplethysmography (PPG) based continuous heart rate measurements.
FIRST EVER SMART WRISTBAND WITH 6-LEAD ECG⁴
What is 6-lead ECG?
Six leads mean that smart wristband with a help of compatible application records 6⁵ highly detailed graphics giving data about cardiac activity. A six-lead ECG provides physicians with information about heart condition, giving the ability to detect arrhythmias⁶.
Leads count
In-Hospital ECG
12 leads
TeltoHeart
6 leads
Non-Wearable Competitors
6 leads
Other Wearable Competitors
1 lead
WHY ATRIAL FIBRILLATION (AF) MATTERS?
Stroke⁷ is one of the most likely outcomes of atrial fibrillation (AF). In-hospital ECG may not display AF if no symptoms occur during the testing. Atrial Fibrillation remains most clinically significant arrhythmia. Prevalence is about 1-3% in general population which is around 200 million people worldwide⁸.
Still wondering if TELTOHEART fits your needs?
CONTINUOUS HEART RATE MONITORING
HEART RATE MONITORING, ALL DAY LONG
Our smart wristband has an integrated photoplethysmography (PPG) monitoring system that can optically obtain a plethysmogram to detect any chages in blood circulation in a real time manner.
Key features:
Still wondering if TELTOHEART fits your needs?
MYHEALTH APP CLINICAL BENEFITS10, 11
TeltoHeart is a wearable system combining PPG-based AF detection algorithm for screening of AF together with an instant 6-lead ECG with no wires for rhythm confirmation.
About one-third of AF patients experience asymptomatic episodes, which equally account for serous thromboembolic risk as symptomatic ones and could be undetected if screened only intermittently. The wearable device TeltoHeart provides continuous photoplethysmography (PPG)-based rhythm monitoring, enabling the detection of asymptomatic AF episodes as short as 30 seconds. The capability ensures that even brief, rare and asymptomatic AF episodes are not missed, contributing to early-stage diagnosis and timely intervention.
TeltoHeart offers a highly accurate PPG-based algorithm for continuous AF detection, with a sensitivity of 94.2% and specificity of 96.9% when compared to a control group of not only stable sinus rhythm (SR) but also SR with frequent premature contractions. This level of accuracy is essential for the peace of mind of our patients and correct notification to record ECG for rhythm confirmation.
The number of premature beats per minute is the main factor associated with false positive detections in the real-world use of wearables. The widespread use of common single-lead ECGs recorded by other smartwatches or handheld devices significantly increases the risk of false-positive detection in populations with frequent premature contractions. The use of a distinguished six-lead ECG feature required 3.4 times more premature beats to result in a false positive outcome compared to single-lead ECG. Thus, TeltoHeart is a robust tool able to maintain a high specificity despite the challenge posed by ectopic beats.
TeltoHeart non-invasive and unobtrusive design allows patients to be continuously monitored for AF and related arrhythmias without disrupting their daily activities. This patient-centered approach promotes early detection and management, reducing the risk of complications and promoting self- care and motivation to improve health.
Due to life in rural areas and various socio-economic reasons not every patient has equal access to healthcare services. Wearable technologies like this wrist-worn TeltoHeart have the potential to bridge healthcare gaps in remote areas, enabling access to accurate cardiac monitoring and timely intervention for individuals who may not have easy access to medical facilities.
Global clients that already trust us.
Countries that we are operating in.
Producing innovative technology solutions.
Devices produced by Teltonika already deployed worldwide.
STAY TUNED!
Subscribe to our newsletter and get latest TELTOHEART updates.
¹ Available 2023.
² Compatible with a application TeltoHeart that allows user to record a 6-lead5 ECG.
³ Available with TeltoHeart app. Atrial fibrillation (Irregular rhythm) notification requires the latest version of watchOS and iOS. It is not intended for use by people under 22 years old.
⁴ Function available with TeltoHeart application.
⁵ TeltoHeart have 3 physical electrodes with which you can physically record the ECG. Other 3 are calculated.
⁶ More information could be found here: https://www.webmd.com/heart-disease/atrial-fibrillation/heart-disease-abnormal-heart-rhythm
⁷ TeltoHeart is not intended for stroke detection.
⁸ More information could be found here: https://globalheartjournal.com/articles/10.5334/gh.1023/
⁹ TeltoHeart have a water resistance rating IP67. However, they should not be used for sea and ocean swiming, scuba diving, waterskiing, or other activities involving high-velocity water or submersion below shallow depth.